New study aims to spot hidden heart danger in genetic AFib patients

NCT ID NCT06575881

Recruiting now Knowledge-focused Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study looks at 200 adults with early-onset atrial fibrillation and certain genetic variants. Researchers will use cardiac MRI and electrophysiologic mapping during scheduled heart procedures to find who is at high risk for ventricular tachycardia, a dangerous heart rhythm. The goal is to better understand and predict this risk, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better predict who is at risk for life-threatening heart rhythms, leading to earlier prevention.
What could go wrong: This is an observational study, not a treatment trial. It may not lead to immediate changes in care, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation Ventricular Premature Complexes ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION PREMATURE VENTRICULAR CONTRACTION VENTRICULAR TACHYCARDIA

Contacts and locations

Locations

Vanderbilt University Medical Center
RECRUITING

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.